2019 Q4 Form 10-Q Financial Statement
#000135657619000045 Filed on November 08, 2019
Income Statement
Concept | 2019 Q4 | 2019 Q3 | 2018 Q4 |
---|---|---|---|
Revenue | $100.4M | $102.1M | $115.9M |
YoY Change | -13.36% | -0.83% | 31.15% |
Cost Of Revenue | $4.100M | $4.819M | $4.200M |
YoY Change | -2.38% | 14.55% | 0.0% |
Gross Profit | $96.30M | $97.32M | $111.7M |
YoY Change | -13.79% | -1.49% | 32.5% |
Gross Profit Margin | 95.87% | 95.28% | 96.35% |
Selling, General & Admin | $35.70M | $39.34M | $42.10M |
YoY Change | -15.2% | -3.79% | 24.56% |
% of Gross Profit | 37.07% | 40.43% | 37.69% |
Research & Development | $19.80M | $16.94M | $29.80M |
YoY Change | -33.56% | -17.04% | 83.95% |
% of Gross Profit | 20.56% | 17.41% | 26.68% |
Depreciation & Amortization | $1.700M | $1.600M | $1.700M |
YoY Change | 0.0% | -15.79% | 6.25% |
% of Gross Profit | 1.77% | 1.64% | 1.52% |
Operating Expenses | $55.50M | $56.29M | $71.90M |
YoY Change | -22.81% | -8.2% | 44.09% |
Operating Profit | $40.82M | $39.73M | $39.86M |
YoY Change | 2.41% | 6.01% | 15.86% |
Interest Expense | -$3.300M | $5.662M | $100.0K |
YoY Change | -3400.0% | 5562.0% | -88.89% |
% of Operating Profit | -8.09% | 14.25% | 0.25% |
Other Income/Expense, Net | $3.400M | -$139.0K | -$1.200M |
YoY Change | -383.33% | -87.41% | 500.0% |
Pretax Income | $40.90M | $39.59M | $38.80M |
YoY Change | 5.41% | 8.85% | 10.54% |
Income Tax | $7.800M | $10.73M | $12.90M |
% Of Pretax Income | 19.07% | 27.1% | 33.25% |
Net Earnings | $33.13M | $28.86M | $25.89M |
YoY Change | 27.95% | 3.03% | 89.0% |
Net Earnings / Revenue | 32.98% | 28.26% | 22.33% |
Basic Earnings Per Share | $0.63 | $0.55 | $0.50 |
Diluted Earnings Per Share | $0.62 | $0.54 | $0.48 |
COMMON SHARES | |||
Basic Shares Outstanding | 52.46M shares | 52.45M shares | |
Diluted Shares Outstanding | 53.81M shares |
Balance Sheet
Concept | 2019 Q4 | 2019 Q3 | 2018 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $347.1M | $296.7M | $356.0M |
YoY Change | -2.5% | 5.89% | 154.29% |
Cash & Equivalents | $181.4M | $116.9M | $192.2M |
Short-Term Investments | $165.7M | $179.8M | $163.8M |
Other Short-Term Assets | $11.60M | $18.20M | $8.900M |
YoY Change | 30.34% | 95.7% | 36.92% |
Inventory | $26.63M | $25.50M | $25.66M |
Prepaid Expenses | |||
Receivables | $87.33M | $86.70M | $102.9M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $472.6M | $427.1M | $493.5M |
YoY Change | -4.22% | 9.34% | 115.97% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $17.07M | $9.977M | $4.095M |
YoY Change | 316.8% | 44.59% | -19.71% |
Goodwill | $0.00 | ||
YoY Change | |||
Intangibles | $24.84M | $26.10M | $31.37M |
YoY Change | -20.81% | ||
Long-Term Investments | $591.8M | $596.4M | $418.8M |
YoY Change | 41.31% | 29.57% | 213.47% |
Other Assets | $21.89M | $574.0K | $380.0K |
YoY Change | 5661.58% | -98.21% | -98.21% |
Total Long-Term Assets | $687.6M | $679.8M | $484.3M |
YoY Change | 41.98% | 27.81% | 147.1% |
TOTAL ASSETS | |||
Total Short-Term Assets | $472.6M | $427.1M | $493.5M |
Total Long-Term Assets | $687.6M | $679.8M | $484.3M |
Total Assets | $1.160B | $1.107B | $977.8M |
YoY Change | 18.66% | 19.99% | 130.34% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $10.14M | $3.090M | $3.195M |
YoY Change | 217.4% | -68.47% | -53.01% |
Accrued Expenses | $49.71M | $138.9M | $36.54M |
YoY Change | 36.07% | 17.61% | -61.78% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $160.6M | $149.7M | $161.4M |
YoY Change | -0.47% | 8.26% | 31.18% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $345.2M | $341.2M | $329.5M |
YoY Change | 4.76% | 4.76% | |
Other Long-Term Liabilities | $28.66M | $11.21M | $11.40M |
YoY Change | 151.42% | -69.37% | -66.48% |
Total Long-Term Liabilities | $28.66M | $11.21M | $11.40M |
YoY Change | 151.42% | -96.91% | -66.48% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $160.6M | $149.7M | $161.4M |
Total Long-Term Liabilities | $28.66M | $11.21M | $11.40M |
Total Liabilities | $564.9M | $549.7M | $524.8M |
YoY Change | 7.63% | 9.8% | 234.26% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $199.5M | $166.4M | $86.49M |
YoY Change | 130.71% | ||
Common Stock | $53.00K | $52.00K | $52.00K |
YoY Change | 1.92% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $595.4M | $557.3M | $453.0M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.160B | $1.107B | $977.8M |
YoY Change | 18.66% | 19.99% | 130.34% |
Cashflow Statement
Concept | 2019 Q4 | 2019 Q3 | 2018 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $33.13M | $28.86M | $25.89M |
YoY Change | 27.95% | 3.03% | 89.0% |
Depreciation, Depletion And Amortization | $1.700M | $1.600M | $1.700M |
YoY Change | 0.0% | -15.79% | 6.25% |
Cash From Operating Activities | $43.80M | $37.60M | $32.90M |
YoY Change | 33.13% | -39.74% | -9.37% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.000M | -$500.0K | -$100.0K |
YoY Change | 1900.0% | 400.0% | -85.71% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $21.50M | -$7.900M | $34.50M |
YoY Change | -37.68% | -130.98% | -287.5% |
Cash From Investing Activities | $19.50M | -$8.400M | $34.30M |
YoY Change | -43.15% | -133.2% | -279.58% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 1.200M | 300.0K | 1.200M |
YoY Change | 0.0% | -62.5% | 0.0% |
NET CHANGE | |||
Cash From Operating Activities | 43.80M | 37.60M | 32.90M |
Cash From Investing Activities | 19.50M | -8.400M | 34.30M |
Cash From Financing Activities | 1.200M | 300.0K | 1.200M |
Net Change In Cash | 64.50M | 29.50M | 68.40M |
YoY Change | -5.7% | -66.67% | 271.74% |
FREE CASH FLOW | |||
Cash From Operating Activities | $43.80M | $37.60M | $32.90M |
Capital Expenditures | -$2.000M | -$500.0K | -$100.0K |
Free Cash Flow | $45.80M | $38.10M | $33.00M |
YoY Change | 38.79% | -39.04% | -10.81% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001356576 | ||
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
130000000 | shares |
CY2019Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
130000000 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
52316583 | shares |
CY2019Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
52462936 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
52316583 | shares |
CY2019Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
52462936 | shares |
CY2019Q3 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
0 | USD |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-35518 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
SUPERNUS PHARMACEUTICALS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-2590184 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1550 East Gude Drive | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Rockville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MD | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20850 | ||
dei |
City Area Code
CityAreaCode
|
301 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
838-2500 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value per share | ||
CY2019Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
52462936 | shares |
CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
25659000 | USD |
CY2019Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
18182000 | USD |
dei |
Trading Symbol
TradingSymbol
|
SUPN | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2019Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
116889000 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
192248000 | USD |
CY2019Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
179808000 | USD |
CY2018Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
163770000 | USD |
CY2019Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
86699000 | USD |
CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
102922000 | USD |
CY2019Q3 | us-gaap |
Inventory Net
InventoryNet
|
25504000 | USD |
CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8888000 | USD |
CY2019Q3 | us-gaap |
Assets Current
AssetsCurrent
|
427082000 | USD |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
493487000 | USD |
CY2019Q3 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
596442000 | USD |
CY2018Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
418798000 | USD |
CY2019Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9977000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4095000 | USD |
CY2019Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
26101000 | USD |
CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
31368000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
18780000 | USD |
CY2019Q3 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
27953000 | USD |
CY2018Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
29683000 | USD |
CY2019Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
574000 | USD |
CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
380000 | USD |
CY2019Q3 | us-gaap |
Assets
Assets
|
1106909000 | USD |
CY2018Q4 | us-gaap |
Assets
Assets
|
977811000 | USD |
CY2019Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3090000 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3195000 | USD |
CY2019Q3 | supn |
Accrued Product Returns And Rebates
AccruedProductReturnsAndRebates
|
98050000 | USD |
CY2018Q4 | supn |
Accrued Product Returns And Rebates
AccruedProductReturnsAndRebates
|
107063000 | USD |
CY2019Q3 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
40800000 | USD |
CY2018Q4 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
36535000 | USD |
CY2019Q3 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
4818000 | USD |
CY2018Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
12377000 | USD |
CY2019Q3 | supn |
Non Recourse Debt Sale Of Future Royalties Current
NonRecourseDebtSaleOfFutureRoyaltiesCurrent
|
2959000 | USD |
CY2018Q4 | supn |
Non Recourse Debt Sale Of Future Royalties Current
NonRecourseDebtSaleOfFutureRoyaltiesCurrent
|
2183000 | USD |
CY2019Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
149717000 | USD |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
161353000 | USD |
CY2019Q3 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
341163000 | USD |
CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
39729000 | USD |
CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
37475000 | USD |
CY2018Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
329462000 | USD |
CY2019Q3 | supn |
Non Recourse Debt Sale Of Future Royalties Noncurrent
NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent
|
20305000 | USD |
CY2018Q4 | supn |
Non Recourse Debt Sale Of Future Royalties Noncurrent
NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent
|
22575000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
27256000 | USD |
CY2019Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
11211000 | USD |
CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
11398000 | USD |
CY2019Q3 | us-gaap |
Liabilities
Liabilities
|
549652000 | USD |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
524788000 | USD |
CY2019Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
52000 | USD |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
52000 | USD |
CY2019Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
383525000 | USD |
CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
369637000 | USD |
CY2019Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
7261000 | USD |
CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3158000 | USD |
CY2019Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
166419000 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
86492000 | USD |
CY2019Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
557257000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
453023000 | USD |
CY2019Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1106909000 | USD |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
977811000 | USD |
CY2019Q3 | us-gaap |
Revenues
Revenues
|
102140000 | USD |
CY2018Q3 | us-gaap |
Revenues
Revenues
|
102996000 | USD |
us-gaap |
Revenues
Revenues
|
292309000 | USD | |
us-gaap |
Revenues
Revenues
|
292963000 | USD | |
CY2019Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4819000 | USD |
CY2018Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4207000 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
12547000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
11168000 | USD | |
CY2019Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16943000 | USD |
CY2018Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20422000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
49307000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
59368000 | USD | |
CY2019Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
40649000 | USD |
CY2018Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
40892000 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
122700000 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
117838000 | USD | |
CY2019Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
62411000 | USD |
CY2018Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
65521000 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
184554000 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
188374000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
107755000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
104589000 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
16309000 | USD | |
CY2019Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-139000 | USD |
CY2018Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1104000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1180000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3180000 | USD | |
CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
39590000 | USD |
CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
36371000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
106575000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
101409000 | USD | |
CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10730000 | USD |
CY2018Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8360000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
26648000 | USD | |
CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28860000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28011000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
79927000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
85100000 | USD | |
CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.55 | |
CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.54 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.53 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.64 | ||
CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.52 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.48 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.57 | ||
CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52453384 | shares |
CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52227630 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52392232 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
51897240 | shares | |
CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
53805838 | shares |
CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54239847 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
53898486 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54098330 | shares | |
CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28860000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28011000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
79927000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
85100000 | USD | |
CY2019Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
1337000 | USD |
CY2018Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
8000 | USD |
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
10419000 | USD | |
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-3364000 | USD | |
CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
1337000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-3364000 | USD | |
CY2018Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
8000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
10419000 | USD | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
90346000 | USD | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
81736000 | USD | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
453023000 | USD |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3287000 | USD |
CY2019Q1 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
783000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
18340000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
4585000 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
480018000 | USD |
CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
30197000 | USD |
CY2018Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
28019000 | USD |
CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4022000 | USD |
CY2019Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1377000 | USD |
CY2019Q2 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
263000 | USD |
CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
32727000 | USD |
CY2019Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
4497000 | USD |
CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
522904000 | USD |
CY2019Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3914000 | USD |
CY2019Q3 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
242000 | USD |
CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28860000 | USD |
CY2019Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
1337000 | USD |
CY2019Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
557257000 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
267480000 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
|
269802000 | USD |
CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2635000 | USD |
CY2018Q1 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
2858000 | USD |
CY2018Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
56215000 | USD |
CY2018Q1 | supn |
Purchases Of Convertible Note Hedges Net Of Tax
PurchasesOfConvertibleNoteHedgesNetOfTax
|
-70137000 | USD |
CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
65688000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
26352000 | USD |
CY2018Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-1544000 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
351869000 | USD |
CY2018Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3068000 | USD |
CY2018Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1184000 | USD |
CY2018Q2 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
5462000 | USD |
CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
30737000 | USD |
CY2018Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-1828000 | USD |
CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
390492000 | USD |
CY2018Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2597000 | USD |
CY2018Q3 | supn |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
828000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28011000 | USD |
supn |
Interest Expense Non Recourse Royalty Liability
InterestExpenseNonRecourseRoyaltyLiability
|
4331000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
748000 | USD | |
CY2018Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
8000 | USD |
supn |
Noncash Operating Lease Cost
NoncashOperatingLeaseCost
|
2600000 | USD | |
us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
1825000 | USD | |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
11701000 | USD | |
CY2018Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
421936000 | USD |
us-gaap |
Profit Loss
ProfitLoss
|
79927000 | USD | |
us-gaap |
Profit Loss
ProfitLoss
|
85100000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5029000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5371000 | USD | |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
8052000 | USD | |
us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
3189000 | USD | |
supn |
Interest Expense Non Recourse Royalty Liability
InterestExpenseNonRecourseRoyaltyLiability
|
3096000 | USD | |
supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
5028000 | USD | |
supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
4300000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11223000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8300000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1689000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-6233000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-16344000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
10687000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-155000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6976000 | USD | |
supn |
Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
4236000 | USD | |
supn |
Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
2778000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
141000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
342000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-334000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3066000 | USD | |
supn |
Increase Decrease In Accrued Product Returns And Rebates
IncreaseDecreaseInAccruedProductReturnsAndRebates
|
-9013000 | USD | |
supn |
Increase Decrease In Accrued Product Returns And Rebates
IncreaseDecreaseInAccruedProductReturnsAndRebates
|
17627000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1120000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
5966000 | USD | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-7559000 | USD | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-7390000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-1903000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
90000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
99338000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
96137000 | USD | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
361121000 | USD | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
491654000 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
184467000 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
45271000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
707000 | USD | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1000 | USD | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
679000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-177362000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-447810000 | USD | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
402500000 | USD | |
us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
0 | USD | |
us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
10435000 | USD | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
65688000 | USD | |
supn |
Purchases Of Convertible Note Hedge
PurchasesOfConvertibleNoteHedge
|
0 | USD | |
supn |
Purchases Of Convertible Note Hedge
PurchasesOfConvertibleNoteHedge
|
92897000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2665000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10331000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2665000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
375187000 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-75359000 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
23514000 | USD | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
192248000 | USD |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
100304000 | USD |
CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
116889000 | USD |
CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
123818000 | USD |
us-gaap |
Interest Paid Net
InterestPaidNet
|
2516000 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
35933000 | USD | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
29930000 | USD | |
supn |
Non Cash Capitalized Cost Of Intangible Assets
NonCashCapitalizedCostOfIntangibleAssets
|
495000 | USD | |
supn |
Non Cash Capitalized Cost Of Intangible Assets
NonCashCapitalizedCostOfIntangibleAssets
|
280000 | USD | |
supn |
Property And Equipment Acquired Under Build To Suit Lease Transaction
PropertyAndEquipmentAcquiredUnderBuildToSuitLeaseTransaction
|
0 | USD | |
supn |
Property And Equipment Acquired Under Build To Suit Lease Transaction
PropertyAndEquipmentAcquiredUnderBuildToSuitLeaseTransaction
|
2304000 | USD | |
supn |
Interest Capitalized During Construction Period For Build To Suit Lease Transaction
InterestCapitalizedDuringConstructionPeriodForBuildToSuitLeaseTransaction
|
0 | USD | |
supn |
Interest Capitalized During Construction Period For Build To Suit Lease Transaction
InterestCapitalizedDuringConstructionPeriodForBuildToSuitLeaseTransaction
|
44000 | USD | |
supn |
Facility Lease Financing Obligation
FacilityLeaseFinancingObligation
|
0 | USD | |
supn |
Facility Lease Financing Obligation
FacilityLeaseFinancingObligation
|
2347000 | USD | |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Business</span></div><div style="line-height:120%;padding-top:13px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supernus Pharmaceuticals, Inc. (the Company) was incorporated in Delaware and commenced operations in 2005. The Company is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company markets </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> products: Oxtellar XR for the treatment of epilepsy, and Trokendi XR for the prophylaxis of migraine headache and treatment of epilepsy. The Company has several proprietary product candidates in clinical development that address opportunities in the CNS market.</span></div><div style="line-height:120%;padding-top:13px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company launched Oxtellar XR and Trokendi XR for the treatment of epilepsy in 2013, launched Trokendi XR for the prophylaxis of migraine headache in adolescents and adults in April 2017, and launched Oxtellar XR with an expanded indication to include monotherapy for partial seizures in January 2019.</span></div> | ||
supn |
Number Of Proprietary Commercial Products
NumberOfProprietaryCommercialProducts
|
2 | product | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="line-height:120%;padding-top:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:13px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company bases its estimates on: historical experience; various forecasts; information received from its service providers; and other assumptions that the Company believes are reasonable under the circumstances. Actual results could differ materially from the Company’s estimates. The Company evaluates the methodologies employed in its estimates on an ongoing basis.</span></div> | ||
CY2019Q3 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | USD |
supn |
Sales Return Period Prior To Expiration
SalesReturnPeriodPriorToExpiration
|
P6M | ||
supn |
Sales Return Period
SalesReturnPeriod
|
P12M | ||
supn |
Number Of Commercial Products
NumberOfCommercialProducts
|
2 | product | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | ||
supn |
Threshold Limit For Medical Claim
ThresholdLimitForMedicalClaim
|
150000 | USD | |
CY2019Q3 | supn |
Self Insurance Liability
SelfInsuranceLiability
|
500000 | USD |
CY2019Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
766570000 | USD |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
586726000 | USD |
CY2019Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
9756000 | USD |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
55000 | USD |
CY2019Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
76000 | USD |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4213000 | USD |
CY2019Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
776250000 | USD |
CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
582568000 | USD |
CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
179808000 | USD |
CY2019Q3 | supn |
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
|
194063000 | USD |
CY2019Q3 | supn |
Available For Sale Securities Debt Maturities Two Years Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesTwoYearsThroughThreeYearsFairValue
|
201889000 | USD |
CY2019Q3 | supn |
Available For Sale Securities Debt Maturities Three Years Through Four Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesThreeYearsThroughFourYearsFairValue
|
200490000 | USD |
CY2019Q3 | supn |
Available For Sale Securities Debt Maturities Thereafter Fair Value
AvailableForSaleSecuritiesDebtMaturitiesThereafterFairValue
|
0 | USD |
CY2019Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
776250000 | USD |
CY2019Q3 | us-gaap |
Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
|
5271000 | USD |
CY2018Q4 | us-gaap |
Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
|
5742000 | USD |
CY2019Q3 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
7050000 | USD |
CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
7275000 | USD |
CY2019Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
13183000 | USD |
CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
12642000 | USD |
CY2019Q3 | us-gaap |
Inventory Net
InventoryNet
|
25504000 | USD |
CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
25659000 | USD |
CY2019Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22307000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
15314000 | USD |
CY2019Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
12330000 | USD |
CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
11219000 | USD |
CY2019Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9977000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4095000 | USD |
CY2019Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
400000 | USD |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1100000 | USD | |
CY2018Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
600000 | USD |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1500000 | USD | |
CY2019Q3 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
40800000 | USD |
CY2018Q4 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
36535000 | USD |
CY2019Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
17274000 | USD |
CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
13356000 | USD |
CY2019Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
26101000 | USD |
CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
31368000 | USD |
CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1300000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3900000 | USD | |
CY2018Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1300000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3900000 | USD | |
CY2019Q3 | supn |
Accrued Clinical Trial And Clinical Supply Costs Current
AccruedClinicalTrialAndClinicalSupplyCostsCurrent
|
17332000 | USD |
CY2018Q4 | supn |
Accrued Clinical Trial And Clinical Supply Costs Current
AccruedClinicalTrialAndClinicalSupplyCostsCurrent
|
14034000 | USD |
CY2019Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
12820000 | USD |
CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
13546000 | USD |
CY2019Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
4003000 | USD |
CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
3706000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3145000 | USD |
CY2018Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
0 | USD |
CY2019Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3500000 | USD |
CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
5249000 | USD |
CY2019Q3 | supn |
Accrued Rebates
AccruedRebates
|
76758000 | USD |
CY2018Q4 | supn |
Accrued Rebates
AccruedRebates
|
85003000 | USD |
CY2019Q3 | supn |
Accrued Product Returns
AccruedProductReturns
|
21292000 | USD |
CY2018Q4 | supn |
Accrued Product Returns
AccruedProductReturns
|
22060000 | USD |
CY2019Q3 | supn |
Accrued Product Returns And Rebates
AccruedProductReturnsAndRebates
|
98050000 | USD |
CY2018Q4 | supn |
Accrued Product Returns And Rebates
AccruedProductReturnsAndRebates
|
107063000 | USD |
CY2018Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
80.9063 | |
CY2018Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
80.9063 | |
CY2018Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
80.9063 | |
CY2019Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
5523000 | USD |
CY2018Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
4461000 | USD |
us-gaap |
Interest Income Other
InterestIncomeOther
|
15657000 | USD | |
us-gaap |
Interest Income Other
InterestIncomeOther
|
9331000 | USD | |
CY2019Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4546000 | USD |
CY2018Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4374000 | USD |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
13425000 | USD | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
9415000 | USD | |
CY2019Q3 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
1116000 | USD |
CY2018Q3 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
1191000 | USD |
us-gaap |
Interest Expense Other
InterestExpenseOther
|
3412000 | USD | |
us-gaap |
Interest Expense Other
InterestExpenseOther
|
3096000 | USD | |
CY2019Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-139000 | USD |
CY2018Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1104000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1180000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3180000 | USD | |
CY2019Q3 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
4000000.0 | USD |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
11700000 | USD | |
CY2018Q3 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3700000 | USD |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
8100000 | USD | |
CY2019Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3914000 | USD |
CY2018Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2597000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
11223000 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8300000 | USD | |
CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28860000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28011000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
79927000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
85100000 | USD | |
CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52453384 | shares |
CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52227630 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52392232 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
51897240 | shares | |
CY2019Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1352454 | shares |
CY2018Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
2012217 | shares |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1506254 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
2201090 | shares | |
CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
53805838 | shares |
CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54239847 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
53898486 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54098330 | shares | |
CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.55 | |
CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.54 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.53 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.64 | ||
CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.52 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.48 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.57 | ||
CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10730000 | USD |
CY2018Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8360000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
26648000 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
16309000 | USD | |
CY2019Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.2710 | |
CY2018Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.2300 | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.2500 | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.1610 | ||
CY2019Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
18780000 | USD |
CY2019Q3 | supn |
Tenant Receivable Leases Additional Allowance For Tenant And Capital Improvement
TenantReceivableLeasesAdditionalAllowanceForTenantAndCapitalImprovement
|
4096000 | USD |
CY2019Q3 | supn |
Lessee Operating Lease Assets
LesseeOperatingLeaseAssets
|
22876000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3145000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
27256000 | USD |
CY2019Q3 | supn |
Lessee Operating Lease Liabilities
LesseeOperatingLeaseLiabilities
|
30401000 | USD |
CY2019Q3 | supn |
Operating Lease Fixed Lease Cost
OperatingLeaseFixedLeaseCost
|
1498000 | USD |
supn |
Operating Lease Fixed Lease Cost
OperatingLeaseFixedLeaseCost
|
3517000 | USD | |
CY2019Q3 | supn |
Operating Lease Variable Lease Cost
OperatingLeaseVariableLeaseCost
|
484000 | USD |
supn |
Operating Lease Variable Lease Cost
OperatingLeaseVariableLeaseCost
|
1467000 | USD | |
CY2019Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1982000 | USD |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
4984000 | USD | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
4048000 | USD | |
supn |
Operating Leases Rent Payments
OperatingLeasesRentPayments
|
4017000 | USD | |
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
31856000 | USD | |
CY2019Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P13Y5M12D | |
CY2019Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0434 | |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
784000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
3089000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2735000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2550000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
2537000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
29371000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
41066000 | USD |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
10665000 | USD |
CY2019Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
30401000 | USD |
CY2018 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
3600000 | USD |
CY2017 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
2700000 | USD |
CY2016 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
2700000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
3400000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
2287000 | USD |
CY2018Q4 | supn |
Operating Leases Future Minimum Payments Thereafter Due
OperatingLeasesFutureMinimumPaymentsThereafterDue
|
1840000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
7527000 | USD |
CY2019Q3 | supn |
Allowance For Expected Sales Deductions
AllowanceForExpectedSalesDeductions
|
10400000 | USD |
CY2018Q4 | supn |
Allowance For Expected Sales Deductions
AllowanceForExpectedSalesDeductions
|
11500000 | USD |
CY2019Q3 | us-gaap |
Revenues
Revenues
|
102140000 | USD |
CY2018Q3 | us-gaap |
Revenues
Revenues
|
102996000 | USD |
us-gaap |
Revenues
Revenues
|
292309000 | USD | |
us-gaap |
Revenues
Revenues
|
292963000 | USD | |
CY2019Q3 | supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
1600000 | USD |
supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
5000000.0 | USD | |
CY2018Q3 | supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
1500000 | USD |
supn |
Revenue From Royalty Agreement
RevenueFromRoyaltyAgreement
|
4300000 | USD | |
CY2014Q3 | supn |
Non Recourse Debt Sale Of Future Royalties Noncurrent
NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent
|
30000000.0 | USD |